Dublin, March 20, 2025 (GLOBE NEWSWIRE) -- The "Pregabalin (CAS 148553-50-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ...

Pregabalin misuse associated with thousands of deaths over five years Rising mortality rates underscore the urgent need for regulatory measures Tragic stories like Alex Cottam's highlight the ...

The efficacy of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy has been established in several controlled clinical trials. [17,18,19] These trials ...

Pregabalin is used to treat conditions including epilepsy, nerve pain and anxiety on the NHS, external. It comes as tablets, capsules or in liquid form, and may be called Alzain, Axalid or Lyrica ...

A Belfast man accused of having a sawn-off shotgun and assorted ammunition stored at his former home as part of a suspected ...

A bereaved mother has warned of the dangers of the prescription drug pregabalin following the death of her 21-year-old daughter. Jasmin Duddy was found unresponsive at a house in Galliagh in Derry ...

According to the report, the global pregabalin industry generated $1.6 billion in 2022 and is anticipated to generate $2.2 billion by 2032, witnessing a CAGR of 3% from 2023 to 2032.

Pregabalin targets the a2-delta auxiliary subunit of voltage-gated calcium channels. Patients with RDEB in this small trial experienced improvements in both pain and itch after pregabalin treatment.

The licenses of four pharmaceutical firms in Jammu and Kashmir have been revoked due to their involvement in the illegal ...

Jammu: Cracking down on the illegal sale of habit-forming pharmaceutical drugs, the Jammu and Kashmir Drugs Control ...

Chandigarh: Pregabalin, a prescription drug used to treat neurological conditions, has emerged as a growing threat in Punjab's deepening drug crisis. .

Pregabalin was made a class C drug in 2019. That means it is illegal to possess pregabalin without a valid prescription, or to supply it to others.